US Patent Issued to KING FAISAL UNIVERSITY on July 7 for "5-(3-bromophenyl)-3-((diethylamino)methyl)-5-methylimidazolidine-2,4-dioneas" (Saudi Arabia Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,922, issued on July 7, was assigned to KING FAISAL UNIVERSITY (Al-Ahsa, Saudi Arabia).

"5-(3-bromophenyl)-3-((diethylamino)methyl)-5-methylimidazolidine-2,4-dioneas" was invented by Yousef Saad Yousef Aldabayan (Al-Ahsa, Saudi Arabia) and Hany Mohamed Abd El-Lateef Ahmed (Al-Ahsa, Saudi Arabia).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound 5-(3-bromophenyl)-3-((diethylamino)methyl)-5-methylimidazolidine-2,4-dione, its synthesis, use as an antibacterial agent and an inhibitor of Chronic Obstructive Pulmonary Disease (COPD)."

The patent was filed on Nov. 20, 2025, under Application No. 19/395,521.

*For further information, including images...